yup, probably picked up by his team and Berkshire Hathway’s only biotech buy so far .... and one of the non- performing one stocks in his portfolio
Biotech is high risk investment... 50:50 could go either way and he is known for safer investment and holding
Would you blindly hold a biotech even if they keep flipping negative results and unable to deliver a marketable product?
Anyway, its MSB thread not Berkshire Hathways or Biogen’s
yup, probably picked up by his team and Berkshire Hathway’s only...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
-0.035(3.41%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.04 | 96.5¢ | $8.837M | 8.885M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 59782 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 26617 | 2 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |